SBI Securities’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51.6K Sell
9,796
-2,036
-17% -$10.7K ﹤0.01% 1146
2026
Q1
$49.5K Sell
11,832
-235
-2% -$1.13K ﹤0.01% 1100
2025
Q4
$58K Sell
12,067
-5,332
-31% -$25.8K ﹤0.01% 1030
2025
Q3
$88K Sell
17,399
-36,677
-68% -$162K ﹤0.01% 889
2025
Q2
$218K Buy
54,076
+2,472
+5% +$8.05K 0.01% 564
2025
Q1
$141K Buy
51,604
+4,256
+9% +$15.3K ﹤0.01% 634
2024
Q4
$201K Buy
+47,348
New +$180K 0.01% 536

Other funds holding SRTA

SBI Securities's SRTA Position: Q2 2026 in Review

SBI Securities reduced its Strata Critical Medical Inc (SRTA) stake by 17% in Q2 2026, selling an estimated $10.7K and leaving 9,796 shares worth $51.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1146.

SBI Securities first reported a position in SRTA in Q4 2024 and has held it in 7 quarters since. The position peaked at $218K in Q2 2025. 139 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • SBI Securities held 9,796 shares of Strata Critical Medical Inc worth $51.6K as of Q2 2026.
  • SBI Securities sold 2,036 Strata Critical Medical Inc shares in Q2 2026, an estimated $10.7K.
  • Strata Critical Medical Inc made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1146 holding.
  • SBI Securities first reported a position in Strata Critical Medical Inc in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Strata Critical Medical Inc position peaked at $218K in Q2 2025.
  • 139 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.